Dublin, April 08, 2026 (GLOBE NEWSWIRE)-- The "Pharmacogenomics Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The Pharmacogenomics Market is ...

An analysis of NHS prescriptions data has revealed the huge potential for pharmacogenomics to reduce ineffective prescribing and adverse effects, which could save millions of pounds for the NHS. The ...

Coronary disease is one of the most significant causes of death among women in the United States; it is responsible for one in every three deaths. Advancing age, along with other contributing factors, ...

Pharmacogenomics (PGx), the study of how genetic profiles impact an individual’s responses to medication, has already begun to help healthcare providers (HCPs) optimize care through its capacity to ...

To permanently access this eBook for free, fill out the short form below. Tools and technologies utilized in PGx research Bridging bench and bedside with PGx Dive into the world of precision medicine, ...

SAN FRANCISCO & HOUSTON--(BUSINESS WIRE)--Aranscia, a global provider of diagnostics software, services, and testing solutions, and Invitae Corporation, a leading medical genetics company, today ...

At the 2026 ACMG Annual Clinical Genetics Meeting, experts detailed strategies to expand pharmacogenomics from research into large-scale clinical use. Speakers emphasized actionable genetic insights, ...

The kits & reagents segment accounted for the largest share by product & service in the pharmacogenomics market in 2022. By product & service, the pharmacogenomics market has been further categorized ...

DENVER, Colo. -- Most people are open to the idea of using genetics to improve drug therapies, but they don't fully grasp how it works or how it might affect them. That's the finding of a national ...